Table 1. Baseline characteristics of patients with CAD and the control subjects.
| Variables | CAD n = 110 |
Control n = 110 |
p-value |
|---|---|---|---|
| Age, years | 59.1 ± 11.1 | 57.8 ± 15.5 | 0.526 |
| Sex, M/F | 56/54 | 55/55 | 0.997 |
| TG, mg/dL | 193.6 ± 82.5 | 163.2 ± 69.1 | 0.003 |
| TC, mg/dL | 204.5 ± 60.5 | 169.3 ± 46.5 | < 0.001 |
| HDL-C, mg/dL | 38.7 ± 9.1 | 46.3 ± 13.0 | < 0.001 |
| LDL-C, mg/dL | 101.4 ± 35.8 | 91.4 ± 32.7 | 0.031 |
| Hypertension | 26 (23.6) | 9 (8.1) | 0.002 |
| Diabetes | 28 (24.5) | 11 (10.0) | 0.004 |
| Smoking | 34 (30.9) | 13 (11.8) | 0.003 |
| C-565T genotypes (CC:CT:TT) | (47:48:15) | (60:45:5) | 0.035 |
TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; CAD: coronary artery disease; CC: wild-type; CT: heterozygote; TT: homozygote. n (%).